Subscribe to stay informed!
Johnson & Johnson is currently weighing strategic options for the future of its diabetic-care companies, including West Chester’s Animas, writes John George for…
Animas Corporation of Chesterbrook recently shared encouraging results from a study working to advance a predictive blood glucose-regulating system for patients with Type 1…
Before we send you to this site, please subscribe to our daily newsletter.